XXZJUZXKBFUPQH-IKGGRYGDSA-N
|
|
XXZJUZXKBFUPQH-IKGGRYGDSA-N 속성
- 끓는 점
- 528.8±50.0 °C(Predicted)
- 밀도
- 1.313±0.06 g/cm3(Predicted)
- 용해도
- 클로로포름, DCM 에 용해됨
- 물리적 상태
- 고체
- 물리적 상태
- 단단한 모양
- 산도 계수 (pKa)
- 4.17±0.60(Predicted)
- 색상
- 하얀색
안전
XXZJUZXKBFUPQH-IKGGRYGDSA-N C화학적 특성, 용도, 생산
용도
(2R,?3R,?6S)?-6-?(4-?Fluorophenyl)?tetrahydro-?2-?(4-?hydroxyphenyl)?-2H-pyran-3-carboxylic Acid is an impurity of Ezetimibe (E975000), a drug that lowers plasma cholesterol levels.XXZJUZXKBFUPQH-IKGGRYGDSA-N 준비 용품 및 원자재
원자재
준비 용품
XXZJUZXKBFUPQH-IKGGRYGDSA-N 공급 업체
글로벌( 23)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11927 | 58 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-52878169 15701683040 |
sales@bjcomparison.com | China | 4726 | 58 |
ChemStrong Scientific Co.,Ltd | 0755-0755-66853366 13670046396 |
sales@chem-strong.com | China | 17993 | 56 |
Jinan blalong chemical co. LTD | 2710913286@.com |
1513643261@qq.com | China | 14253 | 58 |
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd | 15850510341 |
shiqingran@wzxchem.com | China | 3576 | 58 |
Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 14092 | 58 |
Meng Cheng Technology (Shanghai) Co., LTD | 400-820-6829 |
sales@mitachieve.com | China | 8864 | 58 |
Nanjing Shizhou Biology Technology Co.,Ltd | 025-85560043 15850508050 |
info@synzest.com | China | 9287 | 58 |
Energy Chemical | 021-58432009 400-005-6266 |
marketing1@energy-chemical.com | China | 44843 | 58 |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 |
3008058303@qq.com | China | 5000 | 58 |
XXZJUZXKBFUPQH-IKGGRYGDSA-N 관련 검색:
Ezetimibe Impurity 93
(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone
Ezetimibe Impurity 79
Ezetimibe Impurity 36
Ezetimibe Impurity 82
ent-Ezetimibe Ketone
3-O-Acetyl Ezetimibe
EzetiMibe ring-opening dehydrate iMpurity
(3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one
2-{[(4-fluorophenyl)imino]methyl}phenol
2-Oxazolidinone, 3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-, (4S)-rel-
(R)-3,3-Diphenyl-1-methylpyrrolidino[1,2-c]-1,3,2-oxazaborole
4-BENZOYLBUTYRIC ACID
(4S)-3-(2,2-dimethylpropanoyl)-4-phenyl-1,3-oxazolidin-2-one
4a€-O-Benzyloxy (3S,4S)-Ezetimibe
(3R,4R)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
EzetiMibe (3R,4R,3'S)-IsoMer